Empagliflozin Reference Standards Supplier and Manufacturer in India

Empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, is a widely prescribed medication for the management of type 2 diabetes. Ensuring the purity and quality of empagliflozin and its related impurities is crucial in the drug development process to maintain the safety and efficacy of the final product.

Aquigen Bio Sciences is a leading provider of empagliflozin reference standards in India, catering to the pharmaceutical industry’s research and development needs. As a trusted contract research and manufacturing organization, we offer a comprehensive range of empagliflozin impurity standards to support the development of safe and effective diabetes treatments. Aquigen’s empagliflozin reference standards are meticulously synthesized and characterized to meet the stringent requirements of global regulatory bodies.

By partnering with Aquigen, pharmaceutical companies can access a comprehensive portfolio of empagliflozin reference standards, including but not limited to impurities related to the synthetic process, potential degradation products, and structural analogs. These standards are designed to support method development, validation, and routine quality control analysis of empagliflozin-containing drug products. We take pride in our ability to provide customized solutions and tailored services to meet the unique needs of our clients in the pharmaceutical industry.